Preparation of pepsin trypsin digested gliadin for stimulation experiments.
Celiac disease
Gliadin
Pepsin-trypsin digestion
Stimulation
Journal
Methods in cell biology
ISSN: 0091-679X
Titre abrégé: Methods Cell Biol
Pays: United States
ID NLM: 0373334
Informations de publication
Date de publication:
2023
2023
Historique:
medline:
28
8
2023
pubmed:
26
8
2023
entrez:
25
8
2023
Statut:
ppublish
Résumé
Celiac disease (CD) is a complex immune disorder of the intestine that developes in genetically susceptible individuals. CD develops as an intolerance to ingested gluten proteins (gliadins, secalins, hordeins and avenins), being gliadin one of the most immunogenic. Here we present a protocol for the preparation of digested gliadin for laboratory use, a fundamental axis for in vitro and in vivo stimulation studies related to celiac disease research. The importance of a scrupulous handling of materials, products and laboratory instruments to achieve a lipopolysaccharide free gliadin is explained and emphasized. Therefore, in the present chapter, a step-by-step set-up of the protocol for pepsin trypsin gliadin digestion is explained.
Identifiants
pubmed: 37625875
pii: S0091-679X(22)00188-1
doi: 10.1016/bs.mcb.2022.11.005
pii:
doi:
Substances chimiques
Gliadin
9007-90-3
Pepsin A
EC 3.4.23.1
Trypsin
EC 3.4.21.4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
195-201Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.